Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221.6 USD | -3.69% |
|
-2.85% | -14.37% |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
Jul. 12 | Biogen, Eisai Get Approval for Leqembi in Israel for Treatment of Alzheimer's Disease | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.37% | 32.26B | |
+7.40% | 101B | |
+7.76% | 42.18B | |
+81.37% | 29.79B | |
-12.27% | 16.06B | |
+2.33% | 14.45B | |
-8.56% | 12.01B | |
+182.74% | 10.71B | |
+1.50% | 8.89B | |
-56.23% | 8.83B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Transcript : Biogen Inc. Presents at Goldman Sachs Healthcare CEOs Unscripted 2017, Jan-05-2017 04